To elaborate on the differences in the T cell activation process in CD4+ T cells from MS patients and HCs, we specifically analyzed proteins that displayed a significant change in abundance upon T cell activation in HC and MS (Fig. 1E). The gene discussed is CD4; the disease is myeloid sarcoma.